TotalMarketCap

Onconetix

ONCONasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$3.266 M

$0.55 -15.90%

Close of 6 Nov 2026

As of 6 Nov 2026, Onconetix (ONCO) has a market capitalization of $3.27M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$815.4K

#3473 by revenue

Earnings

-$14.0M

Loss-making

Shares outstanding

3,949,107

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #466Traws PharmaTRAW$3.38M
  2. #467Aptevo TherapeuticsAPVO$3.30M
  3. #468OnconetixONCO$3.27M
  4. #46960 Degrees PharmaceuticalsSXTP$3.18M
  5. #470Ernexa TherapeuticsERNA$3.02M

What if Onconetix were worth as much as…

Open the what-if tool →

Gold $28.2T

$4,785,911

Per share 8,645,070× higher

Bitcoin $1.53T

$258,957.30

Per share 467,770× higher

Apple $5.02T

$850,132.65

Per share 1,535,644× higher

Or at a round number

$5.00M$10.0M$20.0M$50.0M

Where these numbers come from

Share counts and financials for Onconetix are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.